Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

NCT06085976 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Carcinoma
Hepatic Metastasis

Interventions

DRUG: Octreotide
OTHER: Placebo

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra